UA-77297057-1

Posters

presented at scientific conferences

15th European Paediatric Formulation Initiative (EuPFI) Conference

Glasgow, UK

2023

14th European Paediatric Formulation Initiative (EuPFI) Conference

Rome, Italy & Virtual

2022

80th International Pharmaceutical Federation (FIP) World Congress

Seville, Spain

2022

13th European Paediatric Formulation Initiative (EuPFI) Conference

Virtual

2021

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

Virtual

2021

The American College of Obstetricians and Gynechologists (ACOG) Annual Clinical and Scientific Meeting

Virtual

2021

10th European Paediatric Formulation Initiative (EuPFI) Conference

London, UK

2018

British Small Animal Veterinary Association (BSAVA) Congress

Birmingham, UK

2018

9th European Paediatric Formulation Initiative (EuPFI) Conference

Warsaw, Poland

2017

19th Congress of the European Association of Hospital Pharmacists (EAHP)

Barcelona, Spain

2014

9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

Lisbon, Portugal

2014

73rd International Pharmaceutical Federation (FIP) World Congress

Dublin, Ireland

2013

72nd International Pharmaceutical Federation (FIP) World Congress

Amsterdam, Holland

2012

  • Other Scientific Posters

Song, G., Banov, D., Ip, K., Bassani, A.S., Song, H., Carvalho, M. and Day, A.J. (2023) ‘In vitro percutaneous absorption of extemporaneously compounded estradiol formulations’, 1st International Societies for Investigative Dermatology (ISID 2023) Meeting, Poster Presentation. Tokyo, Japan 10-13 May.

Holt, M., Raue, F., Davis, C., Ip, K., Carvalho, M. and Banov, D. (2023) ‘Physicochemical and microbiological stability of melatonin 5 mg/mL oral compounded suspension’, 81st FIP World Congress, Community Pharmacy Section, Poster Presentation. Brisbane, Australia 24-28 September.

Carvalho, M., Davis, C., Iqbal, Z., McCarthy, J. and Day, A.J. (2022) ‘Physicochemical and Microbiological Stability of Ursodiol Oral Compounded Suspensions’, American Society of Health-System Pharmacists (ASHP) Summer Meetings & Exhibition 2022, Poster Presentation. Phoenix, USA 11-15 June.

Song, G., Ip, K., Liu, Y., Banov, D., Bassani, A. and Carvalho, M. (2022) ‘In vitro evaluation of skin distribution and human dermal papilla cells proliferation for minoxidil 5% topical lotion hydrogel’, Society for Investigative Dermatology (SID) 2022 Meeting, Poster Presentation. Portland, USA 18-21 May.

Biundo, B., Carvalho, M., Banov, D. and Day, A.J. (2021) ‘Compounded hormones for female patients: a survey assessment of clinical practices in the U.S.’, The North American Menopause Society (NAMS) 2021 Annual Meeting, Poster Presentation. Washington, USA 22-25 September.

Song, G., Ip, K., Shan, A., Banov, D., Song, H., Bassani, A.S., Carvalho, M. and Day, A.J. (2021) ‘Evaluation of the in vitro percutaneous absorption of progesterone, testosterone, estriol and estradiol topical compounded formulations’, Society for Investigative Dermatology (SID) 2021 Meeting, Poster Presentation. Virtual, 3-8 May.

Albrecht, P.J., Liu, Y., Houk, G., Ruggiero, B., Banov, D., Dockum, M., Carvalho, M., Day, A.J., Rice, F.L. and Bassani, G. (2021) ‘Differential keratinocyte expression of topical pain medication targets from patients with neuropathic pain: implications for personalized pain medicine’, SfN Global Connectome: A Virtual Event, Poster Presentation. Virtual, 11-13 January.

Banwarth, J., Larsen, R., Michael, E. and Carvalho, M. (2015) ‘Case report: treatment of diabetic ulceration with compounded medicines’, 2015 West Coast Pharmacy Exchange, Poster Presentation. California, USA 10-11 April.

Carvalho, M., Banov, F., Banov, D. and Bassani, G. (2014) ‘Compounding opportunities for oncology patients’, Palliative Medicine and Supportive Oncology 17th International Symposium, Poster Presentation. Las Vegas, USA 18-20 September.

Banov, D., Bassani, G., Prescott, B. and Carvalho, M. (2014) ‘Characterization of the human skin percutaneous absorption of lorazepam using the Franz Finite Dose in vitro Permeation Test Model’, PAINWeek, Poster Presentation. Las Vegas, USA 2-5 September.

Banov, D., Vieira-Banov, F., Carvalho, M. and De Almeida, M. (2014) ‘Characterization of the physical and microbiological properties of a powder excipient base (Loxasperse)’, 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Poster Presentation. Lisbon, Portugal 3 April.

Banov, D., Vieira-Banov, F., Carvalho, M. and Almeida, M. (2014) ‘Characterization of the properties of powder excipients commonly used in pharmaceutical compounding’, 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP), Poster Presentation. Lisbon, Portugal 3 April.

Banov, D., Banov, F., Bassani, G. and Carvalho, M. (2013) ‘Advances in scar therapy treatment: case studies’, 28th Annual Clinical Symposium on Advances in Skin & Wound Care, Poster Presentation. Florida, USA 24-27 October.

Bassani, G., Banov, D., Banov, F. and Carvalho, M. (2013) ‘Evaluation of the in vitro human trunk skin percutaneous absorption of Ketamine HCl, Gabapentin, Clonidine HCl and Baclofen using the Franz Skin Finite Dose Model’, PAINWeek, Poster Presentation. Las Vegas, USA 5-6 September.

Carvalho, M., Taylor, K. and Tuleu, C. (2009) ‘Extemporaneously compounded oral medicines in European hospital pharmacies’, 9th ULLA Summer School, Poster Presentation. Copenhagen, Denmark 26 June – 3 July.

Last update: January 2024